Carisma Therapeutics, Inc. (CARM)

NASDAQ: CARM · IEX Real-Time Price · USD

1.100

-0.040 (-3.51%)

At close: Jul 19, 2024, 4:00 PM

1.120

+0.020 (1.82%)

Pre-market: Jul 22, 2024, 7:17 AM EDT

Carisma Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2011
Revenue	15.07	14.92	9.83	26.54	11.24	0	Upgrade
Revenue Growth (YoY)	22.99%	51.71%	-62.95%	136.24%	-	-	Upgrade
Gross Profit	15.07	14.92	9.83	26.54	11.24	0	Upgrade
Selling, General & Admin	25.4	29.53	9.38	29.39	14.3	12.21	Upgrade
Research & Development	74.95	74.13	56.62	25.31	29.19	24.66	Upgrade
Other Operating Expenses	0	0	0	37.23	0	0	Upgrade
Operating Expenses	100.34	103.65	66	91.93	43.49	36.87	Upgrade
Operating Income	-85.27	-88.73	-56.16	-65.39	-32.26	-36.87	Upgrade
Interest Expense / Income	-3.95	-1.94	3.15	0	0	0	Upgrade
Other Expense / Income	-	0.08	1.92	-56.78	-11.31	70.63	Upgrade
Pretax Income	-81.32	-86.88	-61.23	-8.61	-20.95	-107.5	Upgrade
Income Tax	-0.11	0	0	-8.27	1.45	0	Upgrade
Net Income	-81.22	-86.88	-61.23	-0.34	-22.4	-107.5	Upgrade
Preferred Dividends	0	0	0	0	0.15	0	Upgrade
Net Income Common	-81.22	-86.88	-61.23	-0.34	-22.54	-107.5	Upgrade
Shares Outstanding (Basic)	41	34	2	9	6	5	Upgrade
Shares Outstanding (Diluted)	41	34	2	9	6	5	Upgrade
Shares Change	220.24%	1475.33%	-76.66%	54.22%	30.01%	47.20%	Upgrade
EPS (Basic)	-1.96	-2.59	-28.77	-	-3.80	-23.60	Upgrade
EPS (Diluted)	-1.96	-2.59	-28.77	-	-3.80	-23.60	Upgrade
Free Cash Flow	-79.08	-82.31	-9.78	-68.88	-30.85	-37.66	Upgrade
Free Cash Flow Per Share	-1.93	-2.46	-4.59	-7.56	-5.22	-8.28	Upgrade
Dividend Per Share	-	0.361	-	-	-	-	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	-	Upgrade
Operating Margin	-565.71%	-594.75%	-571.10%	-246.34%	-287.09%	-	Upgrade
Profit Margin	-538.81%	-582.34%	-622.60%	-1.27%	-200.64%	-	Upgrade
Free Cash Flow Margin	-524.66%	-551.71%	-99.41%	-259.50%	-274.52%	-	Upgrade
EBITDA	-75.99	-80.55	-51.99	-8.52	-20.83	-107.28	Upgrade
EBITDA Margin	-504.11%	-539.92%	-528.69%	-32.11%	-185.39%	-	Upgrade
Depreciation & Amortization	9.28	8.27	6.09	0.09	0.12	0.22	Upgrade
EBIT	-85.27	-88.82	-58.08	-8.61	-20.95	-107.5	Upgrade
EBIT Margin	-565.71%	-595.31%	-590.61%	-32.43%	-186.47%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).